Tackling depression in cancer patients can extend life

Apr 10, 2008

David Spiegel highlights a research article for Faculty of 1000 Medicine that supports aggressive treatment of depression in cancer patients to extend their life expectancy.

A study recommended by David Spiegel of Faculty of 1000 Medicine (www.f1000medicine.com), looks at the relationship between depression care management and survival rates in older patients. He identifies it as “an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting.”

A leading authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University, Spiegel evaluates the research published in the Annals of Internal Medicine, stressing the finding that “Comorbid depression shortens survival time with cancer, and intervention with medication and psychotherapy can therefore extend survival among cancer patients.”

The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer. Spiegel notes that this “is surprising given the well-known link between depression and poor cardiovascular disease outcome”.

He concludes, “Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.”

Source: BioMed Central

Explore further: Survival differences seen for advanced-stage laryngeal cancer

add to favorites email to friend print save as pdf

Related Stories

Form Devices team designs Point as a house sitter

20 hours ago

A Scandinavian team "with an international outlook" and good eye for electronics, software and design aims to reach success with what they characterize as "a softer take" on home security. Their device is ...

Man pleads guilty in New York cybercrime case

23 hours ago

A California man has pleaded guilty in New York City for his role marketing malware that federal authorities say infected more than a half-million computers worldwide.

Recommended for you

Survival differences seen for advanced-stage laryngeal cancer

Nov 27, 2014

The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a total laryngectomy (removal ...

Gene test aids cancer profile

Nov 27, 2014

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.